AFT Pharmaceuticals (AFP) Stock Price, News & Analysis

Company Overview

AFT Pharmaceuticals Limited, together with its subsidiaries, engages in the development and sale of pharmaceutical products in New Zealand, Australia, Asia, and internationally. It offers products for use in the areas of allergy, cold and flu, digestive health, eye care, first aid, nail care, oral care, pain management, skin care, and supplements, as well as other products. AFT Pharmaceuticals Limited was incorporated in 1997 and is headquartered in Auckland, New Zealand.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: A$296.56 million
• P/E Ratio: 21.55
• Dividend Yield: 0.36%
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: ASX:AFP
• CIK: N/A
• Web: www.aftpharm.com
• Phone: 64 9 488 0232
• Fax: N/A
• Employees: 100
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): A$0.14
• Trailing P/E Ratio: 21.55
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: A$15.61 million
• Net Margins: 7.99%
• Pretax Margin: N/A
• Return on Equity: 19.31%
• Return on Assets: 9.67%

Debt

• Debt-to-Equity Ratio: 36.66
• Current Ratio: 2.30
• Quick Ratio: 0.61

Sales & Book Value

• Annual Sales: A$195.41 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: A$0.74 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 104,870,000
• Free Float: N/A
• Market Cap: A$296.56 million
• Optionable: Not Optionable
• Beta: 0.37